JPRN-jRCT2080221511未知3 期
CS-747S PhaseIII trial -Double-blinded study for evaluation of efficacy and safety of CS-747S in reference to clopidogrel bisulfate in subject with coronary arterial disease who are to undergo elective percutaneous coronary intervention
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 600 人开始时间: 2011年7月12日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Subjects aged 20 or above when written informed consent were signed by the subjects.
- •-CAD patients with coronary artery stenosis identified by coronary angiography or CT scan, and scheduled for elective PCI.
排除标准
- •-High bleeding risk
- •-Subjects with ACS
- •-Liver and/or kidney function impairment
研究者
相似试验
未知
3 期
CS-747S PhaseIII trialJPRN-jRCT2080221302DAIICHISANKYO Co.,Ltd.1,200
未知
1 期
A randomized, double-blind, placebo-controlled, continuous IV infusion for 96 hours, ascending dose study to assess the safety, pharmacokinetics and pharmacodynamics of CS-4771 in Japanese healthy subjectsHealthy male volunteersJPRN-jRCT2080221894DAIICHISANKYO Co.,Ltd.24
进行中（未招募）
1 期
S1007 is a clinical trial for patients with node positive (1-3 positive nodes) Hormone Receptor-Positive and HER2-Negative Breast Cancer who when tested with the Oncotype DX test are shown to have a recurrence Score (RS) of 25 or Less. Patients will be randomised to receive endocrinetherapy +/- chemotherapy.EUCTR2012-000576-42-IECancer Trials Ireland5,000
进行中（未招募）
不适用
CWS-2007-HR: A randomised phase-III trial of the Cooperative Weichteilsarkom Studiengruppe for localised high-risk Rhabdomyosarcoma and localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in children, adolescents, and young adultsEUCTR2007-001478-10-DEniversitätsklinikum Tübingen320
进行中（未招募）
不适用
CWS-2007-HR: A randomised phase-III trial of the Cooperative Weichteilsarkom Studiengruppe for localised high-risk Rhabdomyosarcoma and localised Rhabdomyosarcoma-like Soft Tissue Sarcoma in children, adolescents, and young adults - CWS-2007-HREUCTR2007-001478-10-SEniversitätsklinikum Tübingen320